Henderson John T. - 15 Apr 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Henderson
Issuer symbol
CYTK
Transactions as of
15 Apr 2025
Net transactions value
+$875
Form type
4
Filing time
16 Apr 2025, 16:25:13 UTC
Previous filing
06 Jan 2025
Next filing
14 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $124,200 +20,000 +40% $6.21 69,538 15 Apr 2025 Direct
transaction CYTK Common Stock Sale $123,325 -3,190 -4.6% $38.66 66,348 15 Apr 2025 Direct
holding CYTK Common Stock 83 15 Apr 2025 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Stock Option (Right to Buy) Options Exercise $0 -20,000 -100% $0.000000 0 15 Apr 2025 Common Stock 20,000 $6.21 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).